Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...

Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, but many may discontinue them or never receive a prescription due to ...

One of the most commonly used types of medication to prevent strokes is blood thinners. These medications reduce the risk of ...

Clinically significant reductions in bleeding underscore abelacimab’s strong potential to address an unmet need for patients ...

Various specialists will make up your AFib team. Treatments such as medications, nonsurgical procedures, and surgery can slow your heartbeat and bring it back into a normal rhythm. Your HAS-BLED ...

This article will review the various treatments for atrial fibrillation, including lifestyle changes, medications, and surgical procedures. Atrial fibrillation is common, affecting an estimated 3 ...

Abelacimab, a factor XI inhibitor, demonstrated a 62–69% reduction in major bleeding compared to rivaroxaban in atrial fibrillation patients at moderate-to-high stroke risk, with comparable safety and ...

Our Lady of Lourdes Regional Medical Center is embracing cutting-edge technology to transform how heart conditions are ...

The temporary pause follows reports of four cases of neurovascular events in the US external evaluation study.

another UK project – called STAR Mapping – was launched to apply AI to identify the causes of AFib in the hope that the insights could help patients avoid anti-arrhythmic drug treatment.